Lpath Inc. (LPTN) announced Monday morning that it has been awarded a 2-year $1.45 million grant by the Defense Medical Research and Development Program. The grant will support the study of Lpathomab, for the treatment of neuropathic pain associated with traumatic brain injury.
from RTT - Before the Bell http://ift.tt/28M0VAl
via IFTTT
No comments:
Post a Comment